vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and NorthEast Community Bancorp, Inc. (NECB). Click either name above to swap in a different company.
NorthEast Community Bancorp, Inc. is the larger business by last-quarter revenue ($26.4M vs $13.8M, roughly 1.9× FENNEC PHARMACEUTICALS INC.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -34.7%, a 75.6% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 3.9%). Over the past eight quarters, NorthEast Community Bancorp, Inc.'s revenue compounded faster (1.8% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
FENC vs NECB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $26.4M |
| Net Profit | $-4.8M | $10.8M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 59.0% |
| Net Margin | -34.7% | 40.9% |
| Revenue YoY | 73.8% | 3.9% |
| Net Profit YoY | -141.1% | 5.8% |
| EPS (diluted) | $-0.17 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $26.4M | ||
| Q3 25 | $12.5M | $27.0M | ||
| Q2 25 | $9.7M | $25.9M | ||
| Q1 25 | $8.8M | $25.5M | ||
| Q4 24 | $7.9M | $25.4M | ||
| Q3 24 | $7.0M | $27.6M | ||
| Q2 24 | $7.3M | $27.0M | ||
| Q1 24 | $25.4M | $25.5M |
| Q4 25 | $-4.8M | $10.8M | ||
| Q3 25 | $-638.0K | $11.9M | ||
| Q2 25 | $-3.2M | $11.2M | ||
| Q1 25 | $-1.2M | $10.6M | ||
| Q4 24 | $-2.0M | $10.2M | ||
| Q3 24 | $-5.7M | $12.7M | ||
| Q2 24 | $-5.6M | $12.8M | ||
| Q1 24 | $12.8M | $11.4M |
| Q4 25 | -18.5% | 59.0% | ||
| Q3 25 | -1.5% | 61.6% | ||
| Q2 25 | -28.3% | 59.5% | ||
| Q1 25 | -9.2% | 57.4% | ||
| Q4 24 | -11.8% | 57.0% | ||
| Q3 24 | -74.6% | 63.6% | ||
| Q2 24 | -69.4% | 65.6% | ||
| Q1 24 | 54.2% | 62.7% |
| Q4 25 | -34.7% | 40.9% | ||
| Q3 25 | -5.1% | 44.0% | ||
| Q2 25 | -32.7% | 43.1% | ||
| Q1 25 | -13.3% | 41.4% | ||
| Q4 24 | -25.0% | 40.1% | ||
| Q3 24 | -82.2% | 45.9% | ||
| Q2 24 | -76.5% | 47.5% | ||
| Q1 24 | 50.6% | 44.5% |
| Q4 25 | $-0.17 | $0.78 | ||
| Q3 25 | $-0.02 | $0.87 | ||
| Q2 25 | $-0.11 | $0.82 | ||
| Q1 25 | $-0.04 | $0.78 | ||
| Q4 24 | $-0.02 | $0.74 | ||
| Q3 24 | $-0.21 | $0.95 | ||
| Q2 24 | $-0.20 | $0.97 | ||
| Q1 24 | $0.41 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $81.2M |
| Total DebtLower is stronger | — | $70.0M |
| Stockholders' EquityBook value | $35.5M | $351.7M |
| Total Assets | $70.6M | $2.1B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $81.2M | ||
| Q3 25 | $21.9M | $64.3M | ||
| Q2 25 | $18.7M | $59.4M | ||
| Q1 25 | $22.7M | $89.5M | ||
| Q4 24 | $26.6M | $78.3M | ||
| Q3 24 | $40.3M | $97.8M | ||
| Q2 24 | $43.1M | $113.9M | ||
| Q1 24 | $51.2M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | $19.4M | $170.0M | ||
| Q2 25 | $19.4M | $135.0M | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | $7.0M | ||
| Q2 24 | $31.8M | $47.0M | ||
| Q1 24 | $31.3M | $47.0M |
| Q4 25 | $35.5M | $351.7M | ||
| Q3 25 | $-4.5M | $344.0M | ||
| Q2 25 | $-7.5M | $336.7M | ||
| Q1 25 | $-5.9M | $327.2M | ||
| Q4 24 | $-5.9M | $318.3M | ||
| Q3 24 | $-5.2M | $309.6M | ||
| Q2 24 | $-1.4M | $300.0M | ||
| Q1 24 | $3.0M | $288.9M |
| Q4 25 | $70.6M | $2.1B | ||
| Q3 25 | $49.3M | $2.1B | ||
| Q2 25 | $44.9M | $2.0B | ||
| Q1 25 | $46.4M | $1.9B | ||
| Q4 24 | $44.9M | $2.0B | ||
| Q3 24 | $58.9M | $2.0B | ||
| Q2 24 | $63.2M | $1.9B | ||
| Q1 24 | $69.2M | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | 10.40× | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $52.6M |
| Free Cash FlowOCF − Capex | — | $50.8M |
| FCF MarginFCF / Revenue | — | 192.3% |
| Capex IntensityCapex / Revenue | — | 6.6% |
| Cash ConversionOCF / Net Profit | — | 4.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $89.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $52.6M | ||
| Q3 25 | $1.5M | $14.1M | ||
| Q2 25 | $-3.7M | $15.6M | ||
| Q1 25 | $-4.3M | $10.9M | ||
| Q4 24 | $-1.5M | $48.7M | ||
| Q3 24 | $-2.2M | $14.4M | ||
| Q2 24 | $-8.4M | $11.1M | ||
| Q1 24 | $39.0M | $12.9M |
| Q4 25 | — | $50.8M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | — | $14.2M | ||
| Q2 24 | — | $11.0M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | — | 192.3% | ||
| Q3 25 | — | 50.5% | ||
| Q2 25 | — | 57.3% | ||
| Q1 25 | — | 41.4% | ||
| Q4 24 | — | 189.3% | ||
| Q3 24 | — | 51.5% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 50.3% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | 3.04× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
